Paul Jutte, PhD

Department of Orthopaedics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Dr. Paul Jutte trained in the Netherlands in Nijmegen and Amsterdam for general medicine. He did his orthopedic surgery training in Groningen (1997- 2003) and a fellowship in orthopedic oncology in Bologna (Italy) (2003) and Los Angeles (US) (2005). He did a PhD on spinal tuberculosis (2000-2006). He is associate professor since 2015.

His main interest is in treatment of bone tumors and infections. since 2002 his position is at University Medical Center Groningen, one of the four centers for orthopedic oncology in the Netherlands. His current research is aimed at minimizing tissue damage, improving safety and efficacy of surgical treatment of tumor and infection. He works on local tumor ablation using minimal invasive image guided strategies and intraoperative image guidance with computer assisted surgery and patient specific 3D instruments and implants. He studies diagnosis and treatment of complex infections of biomaterials and bone.

Dr. Jutte is Principal Investigator and wrote more than 80 peer reviewed papers. He is co-program leader of BIOBI (research program on biomaterials and infections at Kolff institute). He is head and principle investigator of the LEAK study, a nationwide study with 38 hospitals participating to find the best way to treat wound leakage after primary hip or knee prosthesis (ZonMW Government financed).

He set up a regional network for orthopedic infections in the North-Eastern Netherlands (NINJA). He is head of the division of orthopedic oncology, chairman of the UMCG soft tissue and bone tumor working group and member of the national bone tumor committee. He is visiting professor since 2015 at Hong Hui Hospital at the Jiaotong University Medical Research Center at Xi’an, China. He has done many lectures and workshops at conferences and universities worldwide.